Dr Martens reported an 18% fall in revenues to £324.6 million in their half-year results. This decline aligns with expectations, reflecting significant challenges faced.
Kenny Wilson mentioned, 'This is a year of transition and we have made good progress with our four main objectives,' highlighting ongoing strategic adjustments amid financial challenges.
The exceptional charges of £92 million due to cost-saving measures led to an adjusted loss of £17.9 million, underscoring the financial impact of restructuring efforts.
Wilson added, 'Encouragingly, trading has been driven by good direct-to-consumer sales of new products supported by our new product-led marketing approach,' indicating a focus on innovation.
Collection
[
|
...
]